We excluded markers that are known to be ubiquitously expressed on all nucleated cells (e.g. HLA) or on tumour cells (e.g. CD47) and focused our attention on five markers (CD57, CD59, CD81, CD164 and CD98) for further interrogation. This evidence concerns the gene CD81 and neoplasm.